HIV Research for Prevention (HIV R4P) Conference

HIV R4P is the world's only scientific meeting dedicated to biomedical HIV prevention research. The conference supports cross-fertilization between research on HIV vaccines, microbicides, PrEP, treatment as prevention, and other biomedical prevention approaches, while also providing a venue to discuss the research findings, questions, and priorities that are specific to advancing each subject.

Population Council presentations and posters will highlight microbicides and multi-purpose prevention technologies.

Please also join us for an interactive satellite session on new multi-purpose prevention approaches to combat HIV and sexually transmitted infections (STIs):

Multi-Purpose Prevention Technologies (MPTs): The Future of HIV and STI Protection?

Friday, 31 October 2014
13:30–15:30
Room 1.61–1.62
RSVP to pubinfo@popcouncil.org

Panel Co-Chairs

  • Manjula Lusti-Narasimhan (World Health Organization)
  • José Fernández Romero (Population Council)

Panel

  • Carolyn Deal (NIAID, National Institutes of Health)
  • Betsy Herold (Albert Einstein College of Medicine)
  • Dorothy Patton (University of Washington)
  • Joe Romano (NWJ Group)
  • John Schiller (NCI, National Institutes of Health)
  • Tom Zydowsky (Population Council)

Sponsored by the Population Council and the World Health Organization.

28-31 October 2014

Cape Town International Convention Centre
Cape Town
South Africa

hivr4p.org/

Population Council Speakers

Tuesday, 28 October

Oral Session    |   11:00 am–12:30 pm | Level 1, Auditorium 2

Thomas Zydowsky Senior Scientist, Head of Pharmaceutical Development, HIV and AIDS

"A novel intravaginal ring (IVR) protects macaques against SHIV-RT infection and reduces HSV-2 shedding after repeated SHIV-RT/HSV-2 co-challenge" (Abstract no. OA03.05, 12:00–12:15 pm)

Oral Abstract Session 03—Animal Model Studies of Microbicides

Oral Session    |   1:30–3:00 pm | Level 2, Roof Terrace Room

Elena Martinelli Scientist

"HSV-2-driven changes in α4β7 expression correlate with increased susceptibility to SHIV ex vivo and in vivo" (Abstract no. OA10.02, 1:45–2:00 pm)

Oral Abstract Session 10—Bacterial Vaginosis and HSV-2: Impact on Genital Immunity 

Wednesday, 29 October

Poster Session    |   10:00–11:00 am | 5:00–6:30 pm | Hall 2, Level 0

Ayodeji Oginni

"Socio-demographic factors associated with uptake of HIV counseling and testing (HCT) among Nigerian youth"

Poster Theme P09—HIV Testing and Counseling

Poster Session    |   10:00–11:00 am | 5:00–6:30 pm | Hall 2, Level 0

Ibrahim Suleiman

"Does HIV counseling and testing change sexual risk behaviors? Findings from a community health center (CHC) in North Central Nigeria"

Poster Theme P09—HIV Testing and Counseling

Poster Session    |   10:00–11:00 am | 5:00–6:30 pm | Hall 2, Level 0

Martha Brady Senior Associate

"ARV-based prevention for women: New data on HIV testing behaviors from potential users of vaginal microbicides in Mpumalanga, South Africa"

Poster Theme P09—HIV Testing and Counseling

Poster Sessions    |   10:00–11:00 am | 5:00–6:30 pm | Hall 2, Level 0

Chiedu Ifekandu

"Are Nigerian healthcare providers (HCP) prepared for men who have sex with men (MSM): Lessons from the mystery client survey in Nigeria"

"The anti-same sex marriage law implications on HIV interventions for men who have sex with men in Nigeria"

Poster Theme P13—Key Populations

Poster Session    |   10:00–11:00 am | 5:00–6:30 pm | Hall 2, Level 0

José Fernández Romero Scientist I

"MZC and 1% TFV gel: Multipurpose prevention approaches"

Poster Theme P14—MPT Development

Poster Session    |   10:00–11:00 am | 5:00–6:30 pm | Hall 2, Level 0

George W. Creasy Medical Director

"First-in-human safety and pharmacokinetics (PK) of a MIV-150/zinc acetate/carrageenan gel (PC-1005)"

Thursday, 30 October

Poster Session    |   10:00–11:00 am | 5:00–6:30 pm | Hall 2, Level 0

Barbara Mensch Senior Associate

"Women's (mis) understanding of male circumcision: A mixed methods study in Zambia"

Poster Theme P29—Circumcision and Acceptability

Poster Session    |   10:00–11:00 am | 5:00–6:30 pm | Hall 2, Level 0

José Fernández Romero Scientist I

"Antiviral activity and mode of action of griffithsin against HSV-2 and HPV: Preliminary studies of a potential non-ARV combination microbicide"

Poster Theme P33—Evaluation of Novel Compounds in Cell-Based Systems

Poster Sessions    |   10:00–11:00 am | 5:00–6:30 pm | Hall 2, Level 0

Barbara Mensch Senior Associate

"Reporting of adherence in the VOICE trial: Does disclosure of product non-use increase at the termination visit?"

"Reporting of challenges to adherence in VOICE: A comparison of quantitative and qualitative self-reports among women during and after the trial"

Poster Theme P42—Participation in Trials: Willingness, Benefits and Challenges

Poster Session

Barbara Friedland Associate

"Factors associated with sexually transmitted infections and HIV risk in the Carraguard Phase 3 trial"

Poster Theme P49—Sexually Transmitted Infections

Poster Session    |   10:00–11:00 am | 5:00–6:30 pm | Hall 2, Level 0

Desmond Iriaye

"Patterns of drug use among people who inject drugs (PWID) and their implications for sexually transmitted infections in northern Nigeria"

Poster Theme P49—Sexually Transmitted Infections

Friday, 31 October

Roundtable    |   8:30–10:00 am | Level 1, Meeting Room 1.60

Naomi Rutenberg Vice President and Director, HIV and AIDS Program

Roundtable 05: Multipurpose Technologies

Co-chair: Manjula Lusti-Narasimhan

Panel: Judy Manning, Joseph Romano, Charu Mullick, Elizabeth Brown, and Elizabeth Bukusi

Satellite Session    |   1:30–3:30 pm | Room 1.61–1.62

José Fernández Romero Scientist I

Satellite Session—Multi-Purpose Prevention Technologies (MPTs): The Future of HIV and STI Protection?

Host Institutions: Population Council and WHO
Co-chair: Manjula Lusti-Narasimhan